Cardiovascular Manifestations and Mechanisms in Patients with COVID-19

Qingyu Dou1, Xin Wei2, Kehua Zhou3

  • 1National Clinical Research Center of Geriatrics, Geriatric Medicine Center, West China Hospital, Sichuan University, Chengdu, China; International Institute of Spatial Lifecourse Epidemiology (ISLE), Hong Kong, China.

Insights

Patients with cardiovascular disease (CVD) face higher mortality from COVID-19. This review details COVID-19

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathology

Background:

  • Patients with pre-existing cardiovascular disease (CVD) or developing cardiovascular complications during COVID-19 infection exhibit increased mortality risk.
  • COVID-19 presents with diverse cardiovascular complications, including acute cardiac injury, myocardial infarction, myocarditis, arrhythmias, heart failure, shock, and thromboembolism (pulmonary embolism).

Purpose of the Study:

  • To systematically review the cardiovascular manifestations, histopathology, and underlying mechanisms of COVID-19.
  • To guide future research and therapeutic strategy development for managing COVID-19-associated cardiovascular complications.

Main Methods:

  • Systematic literature review of cardiovascular aspects in COVID-19 patients.
  • Analysis of reported cardiovascular complications, histopathological findings, and proposed pathomechanisms.

Main Results:

  • COVID-19 can precipitate or exacerbate cardiovascular disease through direct viral effects or indirect mechanisms.
  • Key mechanisms include viral toxicity, RAAS dysregulation, endothelial dysfunction, cytokine storm, and oxygen imbalance.
  • Cardiovascular complications significantly contribute to the morbidity and mortality in COVID-19.

Conclusions:

  • Understanding the intricate relationship between COVID-19 and cardiovascular disease is crucial for effective patient management.
  • Further research into the pathobiology and therapeutic interventions for COVID-19 cardiovascular complications is warranted.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
195
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
227
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
223
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
239
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
211
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
122